Perspectiva general
2019 will be DDI’s 5th Anniversary Conference and will be hosted in October in Shanghai, China, marking an important milestone and signifying the need for continuity in facilitating and exchanging vital information and discussing local challenges, technologies and services in a neutral environment.
Featured
Want to learn more about 5th DIA China Drug Discovery Innovation Conference? You've come to the right site!
¿Quiénes deben asistir?
The DDI platform offers a unique opportunity for key stakeholders to come together and exchange expertise, experience and opinions, bringing together 600+ innovators and key thought leaders including:
- Drug Discovery Scientists
- Clinical Researchers
- Regulatory Affairs Professionals
- Business Developers
- Investors
- Project Managers
- And More!
Program Chair
Dr. WANG Zaiqi
CEO, InxMed
Program Co-Chair
Dr. HE Ruyi
Adjunct Professor, Director of Academic Committee, Center for Regulatory Science, School of Medicine, Tsinghua University; Chief Medical Officer, SDIC Fund Management Co.
Steering Committee
Dr. LU Xianping
Chairman and CEO, Shenzhen Chipscreen Biosciences Co., Ltd.
Dr. WANG Zaiqi
CEO, InxMed
Dr. HE Ruyi
Adjunct Professor, Director of Academic Committee, Center for Regulatory Science, School of Medicine, Tsinghua University; Chief Medical Officer, SDIC Fund Management Co.
Dr. TAO Weikang
CEO, Corp VP and CEO of R&D Centers
Jiangsu Hengrui Medicine Co., Ltd.
Dr. WANG Jingsong
CEO, Harbour Biomed (HBM), China
Ms. Carol ZHU
Senior Vice President and Managing Director, DIA China
Comité del programa
-
Darren Ji Founder & CEO
Elpiscience, China -
Hui Li SVP
Sorrento Therapeutics, United States -
Chenbing Wu Founder and Chief Executive Officer
Epimab Biotherapeutics Inc., China -
Xiaojun (Wendy) Yan, MD, MBA Senior Vice President, Senior Advisor
BeiGene (Beijing) Co., Ltd., China -
Bin Yuan Senior Vice President, Global Head of Corporate Development
CStone Pharmaceuticals , China -
Peter Zhang Chairman & CEO
GenePharma, China
¿Tiene una cuenta?